Life Expectancy After Cardiac Ablation: What the Evidence Shows

Name: Life Expectancy After Cardiac Ablation: What the Evidence Shows
Published: July 14, 2026

10 min

Medically Reviewed : Haley Uher BS, MS, ACSM-CEP, EIM is Carda Health’s Head of Clinical Exercise Physiology, a certified Clinical Exercise Physiologist with 11+ years of experience supporting patients across a wide range of cardiac conditions.

Published on :

July 14, 2026

Last updated on :

July 14, 2026

What Is Cardiac Ablation?

Cardiac ablation is a minimally invasive procedure used to treat abnormal heart rhythms (arrhythmias). During the procedure, a thin, flexible tube called a catheter is guided through a blood vessel, usually in the groin, and threaded up to the heart. Once in place, the catheter delivers targeted energy to destroy tiny areas of heart tissue that are generating or conducting the abnormal electrical signals causing the irregular rhythm.

The energy used can be radiofrequency (heat), cryoablation (extreme cold), or the newer pulsed field ablation (short bursts of electrical energy). By creating small scars in precisely targeted locations, the procedure blocks the faulty electrical pathways and helps restore a normal heart rhythm.

Cardiac ablation is most commonly used to treat atrial fibrillation (AFib), the most prevalent heart arrhythmia, but it is also an effective treatment for supraventricular tachycardia (SVT), atrial flutter, and ventricular tachycardia (VT).

Does Cardiac Ablation Affect Life Expectancy?

This is the central question for most patients considering the procedure. The short answer is that cardiac ablation does not shorten life expectancy, and for many patients, particularly those with AFib, it may extend it by reducing the long-term risks of stroke, heart failure, and cardiovascular death.

Immediate Safety

A large national study published in JACC: Clinical Electrophysiology in 2019 examined over 60,000 patients who underwent catheter ablation for AFib and found that the early mortality rate was 0.46%, roughly 1 in 200 patients. The study defined early mortality as death during the initial hospitalization or during rehospitalization within 30 days.

The strongest predictors of this rare early mortality were procedural complications (most commonly cardiac tamponade), pre-existing heart failure, coagulopathy, anemia, and treatment at low-volume centers (hospitals performing fewer than 21 AFib ablations per year). For patients without these risk factors being treated at experienced centers, the procedural risk is very low.

Long-Term Survival Data

The most robust long-term survival data comes from a large cohort study published in Europace, which tracked 30,601 patients who underwent AFib ablation in Australia and New Zealand over more than a decade. The study found five-year survival of 93% and ten-year survival of 84%. Rehospitalizations for stroke and heart failure were relatively uncommon, occurring in 0.7 and 1.1 per 100 person-years respectively.

Life expectancy after cardiac ablation, highlighting five-year survival, ten-year survival, and early mortality rate.

To put these numbers in context, a 2024 study published in the European Heart Journal found that patients hospitalized for AFib or atrial flutter who were managed without ablation lost an average of 2.6 years of life expectancy compared to the general population. While direct head-to-head comparisons are limited, the evidence strongly suggests that successful ablation, by restoring normal rhythm and reducing the burden of AFib, helps narrow this gap.

Success Rates by Arrhythmia Type

The success of cardiac ablation varies significantly depending on which arrhythmia is being treated. Understanding these differences helps set realistic expectations.

Arrhythmia	Single Procedure	Multiple Procedures	Key Notes
AFib (paroxysmal)	60-80%	70-80%	Best outcomes when performed early; younger, healthier patients do better
AFib (persistent)	40-60%	50-70%	Lower success due to more extensive atrial remodeling
SVT	>90%	>95%	Excellent cure rate; often first-line treatment
Atrial flutter	>90%	>95%	High success; typically a single ablation line in right atrium
Ventricular tachycardia	50-70%	Variable	Depends on underlying heart disease and LV function

A systematic review and meta-analysis published in the Journal of the American Heart Association found that the overall long-term success rate for AFib ablation with multiple procedures was approximately 80%, with an average of 1.5 procedures per patient. Most recurrences occur within the first six to twelve months, and a second procedure can often achieve lasting rhythm control.

Ablation vs. Medication: How Outcomes Compare

For many patients with AFib, the decision between ablation and long-term medication is one of the most important treatment choices they will face. While antiarrhythmic drugs can help control symptoms, they do not cure the underlying rhythm disorder and come with their own side effects and risks. The evidence increasingly favors ablation for certain patient populations.

The landmark CASTLE-AF trial, published in the New England Journal of Medicine, compared catheter ablation to conventional medical therapy in patients who had both AFib and heart failure. The results were striking: ablation reduced the combined endpoint of death and heart failure hospitalization by 38%. Mortality in the ablation group was 13.4% compared to 25.0% in the medication group over roughly three years of follow-up.

The AATAC study reinforced these findings, showing that in patients with heart failure and persistent AFib, catheter ablation was superior to amiodarone in maintaining normal rhythm. Hospitalizations were 31% in the ablation group versus 57% with amiodarone, and mortality was 8% versus 18%.

Also read can heart failure be reversed.

Factors That Affect Long-Term Prognosis After Ablation

While the overall survival data is reassuring, individual outcomes vary. Several factors influence how well a patient does in the years following cardiac ablation.

Type of arrhythmia is one of the strongest determinants. Patients with paroxysmal AFib (intermittent episodes) generally have better outcomes than those with persistent AFib (continuous). SVT and atrial flutter have the highest cure rates.

Heart failure and ejection fraction play a significant role. Patients with reduced heart function face higher baseline risks, though ironically they may also stand to benefit the most from successful ablation, as restoring normal rhythm can improve ejection fraction over time.

Age affects outcomes but does not preclude benefit. A 2023 study of patients aged 80 and older found that ablation significantly reduced cardiovascular events and death compared to medication alone, even in this elderly population.

Other factors include comorbidities (diabetes, kidney disease, and obesity are associated with worse outcomes), operator and hospital volume (high-volume centers have better results), and whether a repeat procedure is needed. Between 20% and 50% of AFib ablation patients experience recurrence at some point, and a second procedure can often achieve lasting success.

Comparison of factors associated with a better outlook versus higher risk after cardiac ablation.

Recovery and What Comes Next

Recovery Timeline

Cardiac ablation is a minimally invasive procedure, and most patients go home within 24 hours. The catheter insertion site (usually in the groin) may be sore for a few days, and mild chest discomfort or fatigue is common during the first week. Most patients return to light daily activities within one to three days and resume full normal activity within one to two weeks.

Cardiac Rehabilitation After Ablation

For patients who undergo ablation for AFib, particularly those with concurrent heart failure or other cardiovascular conditions, cardiac rehabilitation can be an important part of the recovery plan. A structured rehab program provides supervised exercise training, nutritional guidance, education about arrhythmia management, and stress reduction support. These elements work together to strengthen the cardiovascular system, improve exercise tolerance, and reduce the risk of AFib recurrence and other cardiac events.

For patients recovering from ablation who also manage heart failure, hypertension, or other cardiac conditions, completing a full rehab program from home can support both short-term recovery and long-term heart health.

Carda Health's virtual cardiac rehab program makes it possible to complete rehabilitation from home, supervised by a clinical exercise physiologist who monitors vital signs in real time. For patients recovering from ablation who may also be managing heart failure, hypertension, or other cardiac conditions, having an accessible, comprehensive rehab option can support both short-term recovery and long-term heart health.

Learn more in our guides on what is heart rehab and virtual cardiac rehab.

Frequently Asked Questions

What is the success rate of cardiac ablation?

Success rates vary by arrhythmia type. For SVT and atrial flutter, success rates exceed 90% with a single procedure. For atrial fibrillation, single-procedure success ranges from 40% to 80% depending on whether the AFib is paroxysmal or persistent. With multiple procedures (average of 1.5 per patient), the long-term success rate for AFib ablation is approximately 80%.

Can AFib come back after ablation?

Yes. Between 20% and 50% of patients who undergo ablation for AFib experience a recurrence at some point. Most recurrences happen within the first six to twelve months. A second ablation procedure can often achieve lasting rhythm control. Some arrhythmia episodes in the first three months (the blanking period) may be part of the normal healing process and do not necessarily indicate failure.

Is cardiac ablation safer than staying on medication?

For many patients, ablation offers better long-term outcomes than antiarrhythmic medications. The CASTLE-AF trial showed that ablation reduced death and heart failure hospitalization by 38% compared to medical therapy. Antiarrhythmic drugs carry their own risks, including organ toxicity with long-term use. The best choice depends on your individual health profile and should be discussed with your electrophysiologist.

How long does it take to recover from cardiac ablation?

Most patients go home within 24 hours and return to light activities in one to three days. Full recovery typically takes one to two weeks. Strenuous activity is usually restricted for about a week. The heart continues to heal over the first three months as scar tissue forms at the ablation sites.

Is cardiac ablation considered a major surgery?

No. Cardiac ablation is a minimally invasive catheter-based procedure, not open-heart surgery. It is performed through small punctures in the skin (usually at the groin), requires no incisions or general anesthesia in many cases, and most patients go home within 24 hours. However, it is still a procedure performed on the heart and carries some risks, including a small chance of complications.

Is cardiac rehab recommended after ablation?

Cardiac rehab can be beneficial for ablation patients, particularly those with concurrent heart failure, reduced ejection fraction, or other cardiovascular conditions. A structured program helps improve cardiovascular fitness, manage risk factors, and support the lifestyle changes that reduce the risk of arrhythmia recurrence. Virtual cardiac rehab programs make it possible to complete the program from home.